SQM 2019 Form 20-F Summary
Period and context. This is SQM’s audited annual report for the fiscal year ended December 31, 2019—not a standalone fourth-quarter report. The company produces specialty plant nutrients, iodine, lithium and derivatives, potassium products, and industrial chemicals, principally from Chilean caliche and Salar de Atacama brines. Financial statements are prepared under IFRS in U.S. dollars. PwC issued an unqualified audit opinion and reported effective internal control over financial reporting. The auditor highlighted bulk-inventory estimates and litigation contingencies as critical audit matters.
Key financial metrics
| Metric | 2019 | 2018 | Change |
|---|---|---|---|
| Revenue | $1,943.7 million | $2,265.8 million | Down 14.2% |
| Gross profit / margin | $560.1 million / 28.8% | $780.2 million / 34.4% | Margin down 5.6 percentage points |
| Profit before tax | $390.6 million | $621.0 million | Down 37.1% |
| Net profit | $280.6 million | $442.1 million | Down 36.5% |
| Profit attributable to controlling interests | $278.1 million | $439.8 million | Down 36.8% |
| Basic earnings per share and ADS | $1.0567 | $1.6711 | Down |
| Net cash from operating activities | $427.0 million | $524.8 million | Down |
| Capital expenditures | $321.3 million | $244.7 million | Up |
| Total assets / liabilities / equity | $4,684.2 million / $2,549.7 million / $2,134.5 million | $4,268.1 million / $2,130.3 million / $2,137.8 million | Assets and liabilities increased |
Cash and cash equivalents were $588.5 million; cash, cash equivalents and time deposits were reported as approximately $1,094 million. The current ratio was 3.45, versus 4.32 in 2018. Management reported net financial debt of $719.8 million and a net financial debt/adjusted EBITDA ratio of 1.1x. The balance sheet separately reports $1,817.7 million of financial liabilities, including lease liabilities and derivative instruments; debt figures therefore depend on the filing’s definition. Adjusted EBITDA was $645.1 million, down from $883.5 million.
Business performance and changes versus 2018
- Lithium: Revenue fell 31.2% to $505.7 million as average prices dropped 31.2%; sales volume was flat at 45,100 metric tons. Lithium represented 26% of revenue.
- Specialty plant nutrition: Revenue declined 7.4% to $723.9 million; average prices fell about 3.8%, with weaker demand and lower potassium-nitrate volumes. It represented 37% of revenue.
- Iodine: Revenue increased 14.2% to $371.0 million, mainly on prices up 19.4% to about $29/kg, despite sales volume down about 4.4%. It represented 19% of revenue.
- Potassium: Revenue fell 20.7% to $212.2 million as sales volumes declined 28.2%; higher average prices did not offset lower volumes.
- Industrial chemicals: Revenue decreased 12.4% to $94.9 million, mainly reflecting lower volumes.
Cost of sales decreased 6.9% to $1,383.6 million, but rose as a share of revenue to 71.2% from 65.6%. Lower lithium prices and reduced potassium volumes drove the decline in gross profit. Finance expense increased 33.1% to $76.9 million, attributed to higher debt. The Chilean peso depreciated 7.8% against the U.S. dollar during 2019.
Liquidity, debt and capital allocation
Operating cash flow was $427.0 million, while investing activities used $485.5 million, including $321.3 million of property, plant and equipment purchases. Financing activities provided $105.9 million, including $450 million of long-term borrowing and $329.8 million of dividends paid. The audited cash-flow statement reports cash and cash equivalents increased by $32.5 million during 2019.
Financial debt maturities included a $250 million note due April 2020. In January 2020, SQM issued $400 million of 4.25% notes due 2050; management said part of the proceeds would repay the April 2020 maturity. The next significant cash debt maturity was identified as April 2023. The company also issued $450 million of 4.25% notes due 2029 in May 2019. Unused, uncommitted working-capital credit lines were $477 million.
The Board approved an approximately $450 million 2020 capital-expenditure framework, including maintenance and lithium, iodine, nitrate and potassium expansions. Management said it did not expect the program to require external financing and retained the option to delay expansion projects. The Mt. Holland lithium project’s final investment decision was deferred to the first quarter of 2021. Chilean lithium-carbonate capacity was 70,000 metric tons per year, with a target of approximately 120,000 by the second half of 2021; lithium-hydroxide capacity expansion was expected to reach 21,500 metric tons per year around early 2021.
Outlook, risks and contingencies
- COVID-19: The filing reports reduced lithium demand in China and an approximately 2,000-metric-ton reduction to first-quarter 2020 lithium sales estimates. The original 2020 lithium sales-volume expectation of 55,000–60,000 metric tons could be lower. Management said full effects on demand, prices, shipments and operations could not yet be estimated; operations were being run with minimum staffing as a precaution.
- Other 2020 expectations disclosed: Management estimated potassium chloride and sulfate sales volumes could rise 20–25% from 2019, industrial-chemical volumes could increase about 80% as solar-salt deliveries ramped up, and water-soluble potassium-nitrate demand could grow about 6%. These were estimates subject to pandemic and market uncertainty.
- Salar de Atacama dependence: Products originating there accounted for 37% of consolidated revenue in 2019. The Corfo lease and project rights expire December 31, 2030, and renewal is not assured. The agreement includes extraction limits and variable payments that increase with product prices.
- Environmental and water matters: An environmental court ruling in December 2019 invalidated the regulator-approved Salar de Atacama compliance program; appeals were pending. The filing warns of possible renewed sanctions, fines of up to approximately $9 million, facility restrictions or permit revocation. Water extraction restrictions, environmental monitoring and evolving water rules could affect production.
- Legal and regulatory exposure: A U.S. securities class action remained pending, with class certification unresolved. A California groundwater case against SQM North America was ordered retried in February 2020. The filing also describes Chilean tax disputes over the application of mining tax to lithium; it estimates potential assessments of about $69 million for 2016–2019, excluding possible interest and fines, and says no provision was recorded for those potential differences.
- Historical compliance matter: SQM entered a DOJ deferred prosecution agreement and SEC order in 2017 concerning alleged FCPA accounting-control and books-and-records violations, paid penalties totaling about $30.5 million, and completed a compliance-monitor period. The filing notes potential consequences if DPA terms are not met.
- Market and governance risks: Lithium, fertilizer and chemical price volatility, new supply, customer concentration in iodine and lithium, foreign-exchange and energy costs, Chilean political and constitutional change, and the proposed lithium-national-interest and mining-royalty bills could affect results. Tianqi, a lithium competitor, held approximately 25.86% of SQM’s shares and had board representation rights subject to antitrust restrictions.
The 2019 dividend policy contemplated a payout tied to financial tests. The Board recommended distributing 100% of 2019 net income, subject to shareholder approval; the proposed final balance was $0.25414 per share after interim dividends. This recommendation was not yet approved in the filing.
Most important facts for investors to verify
- Track lithium pricing, realized prices, sales volumes and the pace of new global supply, particularly against the company’s COVID-affected 2020 estimates.
- Verify progress and spending on lithium capacity expansions, the Mt. Holland project decision, and whether the $450 million 2020 capital plan is revised.
- Monitor the Salar de Atacama environmental appeal, brine and water extraction conditions, Corfo payments and the path to securing rights beyond 2030.
- Review debt definitions and maturities, including the January 2020 note issuance and repayment of the $250 million April 2020 note; distinguish net debt from total financial liabilities.
- Reconcile the filing’s cash-flow disclosures: the audited statement reports a $32.5 million increase in cash and cash equivalents, while an MD&A summary table shows a $32.4 million decrease. The source text does not explain this discrepancy clearly.
- Confirm the shareholder vote and actual payment of the proposed 2019 final dividend, and assess how future payout decisions balance investment needs and liquidity.
- Follow the U.S. class action, environmental litigation and Chilean lithium-tax disputes, including potential financial exposure and any changes to provisions.